The Story of RU-486 in the United States

DSpace/Manakin Repository

The Story of RU-486 in the United States

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Pinho, Elizabeth en_US
dc.date.accessioned 2012-06-15T20:29:51Z
dc.date.issued 2001 en_US
dc.identifier.citation The Story of RU-486 in the United States (2001 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8889480
dc.description.abstract In this paper, I will navigate you through the fascinating odyssey of RU-486 from its initial development in France to its official entry into the U.S. pharmaceutical market to the post-approval strife in which it is now embroiled. While many assumed that the FDA’s approval of RU-486 on September 28, 2000 would mark the final chapter in the story of the drug’s acceptance as an early pregnancy termination procedure, it actually marked the beginning of a new chapter, which ignited congressional efforts to stymie, or even abort, the growth of this chemical alternative to surgical abortion in the United States. As a result of these congressional efforts, the last chapter in the story of RU-486 remains to be written. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject RU-486 en
dc.subject abortion pill en
dc.subject FDA en
dc.title The Story of RU-486 in the United States en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-06-15T20:29:51Z

Files in this item

Files Size Format View
Pinho.rtf 255.1Kb RTF file View/Open
Pinho.pdf 415.4Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters